2020 - Page 325 of 3607 - Bay Street News

Canadian Stock Exchange News - October 1, 2020

Primo Nutraceuticals Inc. Signs Letter of Intent with Brujera Elixirs Inc. to Formulate 4 Innovative Adaptogenic Mushroom-Infused Beverage Products

VANCOUVER, British Columbia, Oct. 01, 2020 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVD) (FSE: 8BV) (DEU: 8BV) […]

NASDAQ Companies - October 1, 2020

Donegal Group Inc. Announces Third Quarter 2020 Conference Call and Webcast

MARIETTA, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) — Donegal Group Inc. (NASDAQ:DGICA) and (NASDAQ:DGICB) announced that the Company plans to […]

NASDAQ Companies - October 1, 2020

Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.

EWING, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today […]

NASDAQ Companies - October 1, 2020

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

ITP program providing reimbursement for gammaCore™ extended to March. 31, 2021 with option for additional three yearsThe potential contract value […]

Canadian Stock Exchange News - October 1, 2020

Versus Systems Partners With Predictmedix to Develop Products for Healthcare Applications in the Clinical Trial Market

LOS ANGELES, Oct. 01, 2020 (GLOBE NEWSWIRE) — Versus Systems Inc. (“Versus”) (CSE:VS) (OTCQB:VRSSF) (FRANKFURT:BMVA) today signed an agreement with […]

Canadian Stock Exchange News - October 1, 2020

Ayr Strategies Enters into Agreements to Expand Operations to Fourth State with Strategic Acquisitions in Ohio; Deepens Pennsylvania Presence

TORONTO, Oct. 01, 2020 (GLOBE NEWSWIRE) — Ayr Strategies (CSE: AYR.A, OTCQX: AYRSF, “Ayr” or “the Company”), a leading vertically […]

NASDAQ Companies - October 1, 2020

Primo Nutraceuticals Inc. Signs Letter of Intent with Brujera Elixirs Inc. to Formulate 4 Innovative Adaptogenic Mushroom-Infused Beverage Products

Donegal Group Inc. Announces Third Quarter 2020 Conference Call and Webcast

Antares Pharma Enters Exclusive License Agreement With Ferring Pharmaceuticals for Nocdurna® in U.S.

electroCore, Inc. Announces Extension of NHS England’s Innovation and Technology Payment (ITP) Program to Fund Continued Use of gammaCore™ in England

Versus Systems Partners With Predictmedix to Develop Products for Healthcare Applications in the Clinical Trial Market

Ayr Strategies Enters into Agreements to Expand Operations to Fourth State with Strategic Acquisitions in Ohio; Deepens Pennsylvania Presence

Ziopharm Oncology to Participate in Jefferies Cell Therapy Virtual Summit on October 5, 2020

Ziopharm Oncology to Participate in Jefferies Cell Therapy Virtual Summit on October 5, 2020

Align Technology to Announce Third Quarter 2020 Results on October 21, 2020

Align Technology to Announce Third Quarter 2020 Results on October 21, 2020